Clinical Trial Update: Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE) [Phase 3]

View source ↗

Summary

Clinical trial update for CITRINE, a Phase 3 study evaluating intensified chemotherapy with carboplatin for triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Fudan University | Conditions: Triple-negative Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING